In vitro activity and killing effect of temporin A on nosocomial isolates of Enterococcus faecalis and interactions with clinically used antibiotics

J Antimicrob Chemother. 2005 Feb;55(2):272-4. doi: 10.1093/jac/dkh545. Epub 2005 Jan 13.

Abstract

Objective: To study the in vitro activity of temporin A, a basic, highly hydrophobic, antimicrobial peptide amide derived from the skin of the European red frog Rana temporaria, alone and in combination with co-amoxiclav, imipenem, ciprofloxacin, linezolid and vancomycin, against 42 nosocomial isolates of Enterococcus faecalis. Fourteen of these were resistant to vancomycin.

Methods: Antimicrobial activity of temporin A was measured by MIC, MBC and time-kill studies and by the chequerboard titration method.

Results: All isolates were inhibited at concentrations of 1 to 16 mg/L. Combination studies carried out with E. faecalis ATCC 29212 and ATCC 51299 demonstrated synergy only when the peptide was combined with co-amoxiclav and imipenem.

Conclusions: Our findings show that temporin A is active against E. faecalis and that its activity could be enhanced when it is combined with other antimicrobial agents.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Antimicrobial Cationic Peptides
  • Cross Infection / drug therapy*
  • Cross Infection / microbiology
  • Drug Interactions / physiology
  • Enterococcus faecalis / drug effects*
  • Enterococcus faecalis / isolation & purification
  • Humans
  • Microbial Sensitivity Tests / statistics & numerical data
  • Proteins / pharmacology
  • Proteins / therapeutic use*

Substances

  • Anti-Bacterial Agents
  • Antimicrobial Cationic Peptides
  • Proteins
  • temporin